or
forgot password

    • cancer clinical trials in huntsville, AL

    • Laparoscopic-Assisted Surgery Compared With Open Surgery in Treating Patients With Colon Cancer
    Huntsville Hospital System
    Huntsville, Alabama 35801
    Colorectal Cancer
    Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer
    Comprehensive Cancer Institute of Huntsville
    Huntsville, Alabama 35801
    Prostate Cancer
    Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer
    Huntsville Hospital System

    Trial Locations
    Huntsville Hospital System
    Comprehensive Cancer Institute of Huntsville
    Lung Cancer
    Radiation Therapy in Treating Patients With Stage II Cancer of the Vocal Cord
    Comprehensive Cancer Institute of Huntsville
    Huntsville, Alabama 35801
    Head and Neck Cancer
    Radiation Therapy With or Without Bicalutamide in Treating Patients With Stage II, Stage III, or Recurrent Prostate Cancer
    Huntsville Hospital System

    Trial Locations
    Huntsville Hospital System
    Comprehensive Cancer Institute of Huntsville
    Prostate Cancer
    Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer
    Comprehensive Cancer Institute of Huntsville
    Huntsville, Alabama 35801
    Drug/Agent Toxicity by Tissue/Organ, Lung Cancer, Oral Complications, Radiation Toxicity
    Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
    Huntsville Hospital System

    Trial Locations
    Huntsville Hospital System
    Comprehensive Cancer Institute of Huntsville
    Bladder Cancer
    Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
    Huntsville Hospital
    Huntsville, Alabama 35807
    Prostate Cancer
    Radiation Therapy Followed by Carmustine in Treating Patients Who Have Supratentorial Glioblastoma Multiforme
    Huntsville Hospital System

    Trial Locations
    Huntsville Hospital System
    Comprehensive Cancer Institute of Huntsville
    Brain and Central Nervous System Tumors
    Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer
    Comprehensive Cancer Institute of Huntsville
    Huntsville, Alabama 35801
    Colorectal Cancer
    Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
    Huntsville Hospital System

    Trial Locations
    Huntsville Hospital System
    Comprehensive Cancer Institute of Huntsville
    Head and Neck Cancer
    Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    Clearview Cancer Institute
    Huntsville, Alabama 35805
    Endometrial Cancer
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Clearview Cancer Institute
    Huntsville, Alabama 35805
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Erlotinib or Placebo Following Chemoradiotherapy (Chemo/RT) in Stage III Non-Small Cell Lung Cancer (NSCLC)
    Oncology Specialties, P.C.
    Huntsville, Alabama 35801
    Carcinoma, Non-Small-Cell Lung, Non-small Cell Lung Cancer, NSCLC
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Clearview Cancer Institute
    Huntsville, Alabama 35805
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    S-1 as Second-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer
    Comprehensive Cancer Institute
    Huntsville, Alabama 35801
    Pancreatic Cancer
    Study to Assess Steady-State Trough Concentrations, Safety, and Immunogenicity of Abatacept After SC Administration to Subjects With RA
    Rheumatology Associates Of North Alabama, P.C.
    Huntsville, Alabama 35801
    Rheumatoid Arthritis
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Clearview Cancer Institute
    Huntsville, Alabama 35805
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Clearview Cancer Institute
    Huntsville, Alabama 35805
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Clearview Cancer Institute
    Huntsville, Alabama 35805
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Patients With Advanced Non-Small Cell Lung Cancer
    Clearview Cancer Institute Oncology Specialties, P.C.
    Huntsville, Alabama 35805
    Non-Small Cell Lung Carcinoma
    BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab
    Clearview Cancer Institute

    Trial Locations
    Clearview Cancer Institute
    Clearview Cancer Institute- Huntsville
    Breast Cancer
    A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast Cancer
    Cancer Center of Huntsville
    Huntsville, Alabama 35801
    Breast Cancer
    RT, Temozolomide, and Bevacizumab Followed by Bevacizumab/Everolimus in First-line Treatment of GBM
    Clearview Cancer Institute
    Huntsville, Alabama 35805
    Glioblastoma Multiforme
    Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
    Clearview Cancer Institute Oncology Specialities, P.C.
    Huntsville, Alabama 35805
    Metastatic Pancreatic Cancer
    Efficacy and Safety of MORAb-003 in Subjects With Platinum-sensitive Ovarian Cancer in First Relapse
    Oncology Specialties, PC
    Huntsville, Alabama 35805
    Ovarian Cancer
    Connect® MM- The Multiple Myeloma Disease Registry
    The Cancer Center of Huntsville
    Huntsville, Alabama 35801
    Multiple Myeloma
    An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study
    Clearview Cancer Institute
    Huntsville, Alabama 35805
    Chronic Lymphocytic Leukemia, Lymphoma, Non-Hodgkin, Acute Myeloid Leukemia, Multiple Myeloma
    Imetelstat as Maintenance Therapy After Initial Induction Chemotherapy in Non-small Cell Lung Cancer (NSCLC)
    Clearview Cancer Institute
    Huntsville, Alabama 35805
    Non-small Cell Lung Cancer
    Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
    Clinical Research Associates
    Huntsville, Alabama 35801
    Colorectal Neoplasms, Digestive System Diseases, Colonic Diseases, Colorectal Cancer
    Efficacy and Safety Study of CAL-101 in Patients With Indolent B-Cell Non-Hodgkin Lymphoma
    Clearview Cancer Institute
    Huntsville, Alabama 35805
    Indolent Non-Hodgkin Lymphoma, Follicular Lymphoma, Small Lymphocytic Lymphoma, Lymphoplasmacytoid Lymphoma, Marginal Zone Lymphoma
    A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
    Medical Affiliated Research Center, Inc.

    Trial Locations
    Medical Affiliated Research Center, Inc.
    James Gordon McMurray, MD
    Overactive Bladder
    AMR-001 Versus Placebo Post ST Segment Elevation Myocardial Infarction
    Heart Center Research, LLC (Huntsville Hospital)
    Huntsville, Alabama 35801
    ST Segment Elevation Myocardial Infarction
    A Extension Study of Idelalisib for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
    Clearview Cancer Institute
    Huntsville, Alabama 35805
    Chronic Lymphocytic Leukemia
    Study of the Efficacy and Safety of Ublituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
    TG Therapeutics Investigational Trial Site
    Huntsville, Alabama 35805
    Non-Hodgkins Lymphoma, B-cell Lymphoma, Waldenstrom's Macroglobulinemia, Marginal Zone Lymphoma, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Primary Central Nervous System Lymphoma
    Safety Study of CC-292 and Lenalidomide in Subjects With Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma
    Clearview Cancer Center
    Huntsville, Alabama 35801
    Leukemia Lymphocytic Chronic B-Cell
    Safety Study of CC-292 and Rituximab in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
    Clearview Cancer Institute
    Huntsville, Alabama 35805
    Leukemia Lymphocytic Chronic B-Cell
    Ublituximab in Combination With Lenalidomide in Patients With B-Cell Lymphoid Malignancies
    TG Therapeutics Investigational Trial Site
    Huntsville, Alabama 35805
    Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, B-cell Lymphomas, Marginal Zone Lymphoma, Mantle Cell Lymphoma, Waldenstrom's Macroglobulinemia